EPCAM and neoplasm: Zhang et al. recently found that EpCAM-CAR T cells targeted colon cancer cells in an EpCAM-dependent fashion with no systemic toxicity in mice despite eliciting the secretion of cytotoxic cytokines and delaying tumor formation and growth in xenograft models [77].